Follow-Up Data From Phase 3 Trial of Pfizer-BioNTech COVID-19 Vaccine Support Safety and High Efficacy in Adolescents 12 Through 15 Years of AgeBusiness Wire • 11/22/21
Pfizer, BioNTech COVID-19 vaccine authorized in Canada for children 5 to 11 years of ageMarket Watch • 11/19/21
Pfizer and BioNTech Receive Expanded U.S. FDA Emergency Use Authorization of COVID-19 Vaccine Booster to Include Individuals 18 and OlderBusiness Wire • 11/19/21
BioNTech Receives FDA Fast Track Designation for its FixVac Candidate BNT111 in Advanced MelanomaGlobeNewsWire • 11/19/21
BioNTech SE (BNTX) CEO Ugur Sahin on Q3 2021 Results - Earnings Call TranscriptSeeking Alpha • 11/09/21
BioNTech stock reverses lower after earnings report, in which profit and revenue beat expectationsMarket Watch • 11/09/21